Harvard Bioscience
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $22,727 | $20,755 | $23,735 | $20,591 |
Gross Profit | 12,630 | 12,244 | 14,172 | 12,021 |
EBITDA | 1,086 | -3,685 | 504 | 1,156 |
EBIT | -1,103 | -5,035 | -846 | -168 |
Net Income | -2,910 | -3,424 | -2,847 | -1,231 |
Net Change In Cash | 22,727 | 20,755 | 23,735 | 20,591 |
Free Cash Flow | -365 | -1,088 | -695 | 736 |
Cash | 6,503 | 7,098 | 8,614 | 6,817 |
Basic Shares | 4,526 | 4,473 | 4,439 | 4,455 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $86,550 | $94,135 | $112,250 | $113,335 |
Gross Profit | 45,883 | 54,766 | 66,071 | 60,819 |
EBITDA | -46,524 | -1,474 | 8,033 | 944 |
EBIT | -52,469 | -8,456 | 1,035 | -6,631 |
Net Income | -56,700 | -12,405 | -3,415 | -9,516 |
Net Change In Cash | 86,550 | 94,135 | 112,250 | 113,335 |
Cost of Revenue | -3,275 | |||
Free Cash Flow | 5,615 | -1,823 | 11,717 | -438 |
Cash | 8,614 | 4,108 | 4,283 | 4,508 |
Basic Shares | 4,439 | 4,353 | 4,242 | 4,141 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.22 |
2026-03-31 | -$0.77 |
2025-12-31 | -$0.63 |
2025-09-30 | -$0.03 |